article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Cannabis Advocacy With a Digital Twist. RoC also works to increase patients’ access to medical cannabis by helping U.S.

article thumbnail

States That Restrict MMJ Access Are Interfering With Patients’ Rights, Study Shows

Veriheal

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. How Do MMJ Restrictions Affect Patients and Doctors?

Access 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study on MDMA for Traumatic Brain Injury Boosted By $1.5M Donation

SpeedWeed

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

article thumbnail

Press Release: Maya and National Psychedelics Association Announce Partnership to Support Psilocybin-Assisted Services in Oregon

Cannabis Law Report

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

The results are so compelling that the FDA has categorized magic mushrooms as a “breakthrough therapy” for depression, and is committed to fast tracking its approval. History: MDMA was first synthesized in 1912, but it didn’t become popular until 1970, when therapists began to utilize it to enhance openness in therapy sessions.

History 119
article thumbnail

Weekly Legislative Roundup 3/15/18

NORML

Some highlights include expedited expungement for past misdemeanor marijuana convictions, a three-percent tax to be collected by or paid to municipalities wherever retail stores exist, and provisions to incentivize socio-economic, racial, and gender equity in the state’s cannabis industry. LA resident? MD resident?

article thumbnail

Legalization of Cannabis 

Cannabis Law Report

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). percent or 16.7